130 related articles for article (PubMed ID: 7929309)
1. The murine urokinase-type plasminogen activator receptor gene.
Suh TT; Nerlov C; Danø K; Degen JL
J Biol Chem; 1994 Oct; 269(42):25992-8. PubMed ID: 7929309
[TBL] [Abstract][Full Text] [Related]
2. The structure of the urokinase-type plasminogen activator receptor gene.
Casey JR; Petranka JG; Kottra J; Fleenor DE; Rosse WF
Blood; 1994 Aug; 84(4):1151-6. PubMed ID: 8049431
[TBL] [Abstract][Full Text] [Related]
3. Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family.
Wang Y; Dang J; Johnson LK; Selhamer JJ; Doe WF
Eur J Biochem; 1995 Jan; 227(1-2):116-22. PubMed ID: 7531640
[TBL] [Abstract][Full Text] [Related]
4. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor.
Ploug M
Curr Pharm Des; 2003; 9(19):1499-528. PubMed ID: 12871065
[TBL] [Abstract][Full Text] [Related]
6. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.
Wang Y
Med Res Rev; 2001 Mar; 21(2):146-70. PubMed ID: 11223863
[TBL] [Abstract][Full Text] [Related]
7. The murine urokinase-type plasminogen activator gene.
Degen SJ; Heckel JL; Reich E; Degen JL
Biochemistry; 1987 Dec; 26(25):8270-9. PubMed ID: 2831940
[TBL] [Abstract][Full Text] [Related]
8. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
Ploug M
Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
[TBL] [Abstract][Full Text] [Related]
9. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene.
Soravia E; Grebe A; De Luca P; Helin K; Suh TT; Degen JL; Blasi F
Blood; 1995 Jul; 86(2):624-35. PubMed ID: 7605992
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells.
Ploug M; Rahbek-Nielsen H; Nielsen PF; Roepstorff P; Dano K
J Biol Chem; 1998 May; 273(22):13933-43. PubMed ID: 9593742
[TBL] [Abstract][Full Text] [Related]
11. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility.
Bugge TH; Suh TT; Flick MJ; Daugherty CC; Rømer J; Solberg H; Ellis V; Danø K; Degen JL
J Biol Chem; 1995 Jul; 270(28):16886-94. PubMed ID: 7622505
[TBL] [Abstract][Full Text] [Related]
12. A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor.
Dang J; Boyd D; Wang H; Allgayer H; Doe WF; Wang Y
Eur J Biochem; 1999 Aug; 264(1):92-9. PubMed ID: 10447677
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
Ploug M; Ostergaard S; Hansen LB; Holm A; Danø K
Biochemistry; 1998 Mar; 37(11):3612-22. PubMed ID: 9521680
[TBL] [Abstract][Full Text] [Related]
14. The small-GTPase RalA activates transcription of the urokinase plasminogen activator receptor (uPAR) gene via an AP1-dependent mechanism.
Okan E; Drewett V; Shaw PE; Jones P
Oncogene; 2001 Apr; 20(15):1816-24. PubMed ID: 11313929
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.
Lund LR; Ellis V; Rønne E; Pyke C; Danø K
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):345-52. PubMed ID: 7646466
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
17. Sequences within domain II of the urokinase receptor critical for differential ligand recognition.
Li Y; Lawrence DA; Zhang L
J Biol Chem; 2003 Aug; 278(32):29925-32. PubMed ID: 12761227
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.
Ploug M; Gårdsvoll H; Jørgensen TJ; Lønborg Hansen L; Danø K
Biochem Soc Trans; 2002 Apr; 30(2):177-83. PubMed ID: 12023847
[TBL] [Abstract][Full Text] [Related]
19. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
Olson D; Pöllänen J; Høyer-Hansen G; Rønne E; Sakaguchi K; Wun TC; Appella E; Danø K; Blasi F
J Biol Chem; 1992 May; 267(13):9129-33. PubMed ID: 1315748
[TBL] [Abstract][Full Text] [Related]
20. Ligand binding regions in the receptor for urokinase-type plasminogen activator.
Liang OD; Chavakis T; Kanse SM; Preissner KT
J Biol Chem; 2001 Aug; 276(31):28946-53. PubMed ID: 11501527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
